tion, and the uPAR level was associated with liver metastasis. The VEGF level was signifi cantly correlated with the levels of uPAR and PAI-1. These results reveal that IL-8, VEGF, and PA system factors are contributed to tumor growth, invasion, and metastasis in CRC. Univariate analysis revealed that high levels of IL-8, VEGF, and uPAR were signifi cantly associated with a shorter overall survival time; however, multivariate analysis identifi ed only liver metastasis as an independent prognostic factor. In conclusion, IL-8 is responsible to tumor progression and liver metastasis of CRC, and the activation of PAS induced by IL-8 as well as VEGF may play an important role in the progression of CRC.
and cancer cells [4] [5] [6] . IL-8 has mitogenic activity, enhances cell adhesion, and upregulates urokinase-type plasminogen activator (uPA) or metalloprotease-9 activity [7, 8] . On the other hand, VEGF has been reported to increase the permeability of tumor vessels [9] , to induce serine proteases or metalloproteases [10, 11] , and to inhibit either the apoptosis of endothelial cells [12, 13] or the maturation of dendritic cells [14] . Many clinical studies have shown that the levels of IL-8 or VEGF are correlated with various clinicopathological variables and have a signifi cant impact on survival [15] [16] [17] .
Plasminogen activator system (PA system) factors are regarded to be representative invasive factors as well as metalloprotease-2 and -9 in various solid tumors. The uPA and uPA receptor (uPAR) are key molecules in tumor cell proliferation and invasion [18] . The uPAR is a cell membrane-anchored binding protein for uPA that causes PA activity to accumulate at cell surfaces [18, 19] . The relevance of the PA system to tumor progression has been demonstrated by the poor prognosis of patients with a high level of uPA or uPAR in tumor tissues [18, [20] [21] [22] . Plasminogen activator inhibitor-1 (PAI-1) and PAI-2 are two specifi c PA inhibitors that belong to the serine protease inhibitor superfamily, and they play an important role in the regulation of uPA activity in tumors [23] . High levels of PAI-1 in tumor tissues were reported to be associated with a poor prognosis [24] [25] [26] , and PAI-1 was suggested to promote tumor growth by modifying cell adhesion [27, 28] .
We previously reported the existence of a relationship between VEGF and the PA system, which promote angiogenesis synergistically in CRC [29] . In this context, we investigated the relationship of IL-8 with VEGF and PA system factors in CRC.
Material and Methods

Patient and Tissue Extracts
Tumors and adjacent normal specimens were obtained from 87 patients who underwent surgery for CRC at the Hamamatsu University School of Medicine between January 1994-April 1996. All specimens were examined for histological diagnosis, degree of differentiation, lymph node involvement, and other clinicopathological variables. Tumors and adjacent normal specimens were frozen quickly and store at -80 ° C until homogenization. Tissue samples were homogenized with 10 times as much volume of buffer (0.1 M Tris-HCl, pH 7.5, containing 0.15 M NaCl and 1% Triton X-100) using a Physcotron microhomogenizer (NITI-ON, Tokyo, Japan). After incubation at 4 ° C for 12 h, homogenized samples were centrifuged at 4 ° C at 12,000 g for 10 min. Supernatants were stored at -80 ° C until they were assayed.
ELISA for IL-8, VEGF, and PA System Factors
The antigen levels of IL-8, VEGF, uPA, uPAR, PAI-1, and PAI-2 in the supernatant of the homogenized tissue samples were assayed with commercially available enzyme-linked immunosorbent assay (ELISA) kits according to the methods recommended by the manufacturers (IL-8: Diaclone SAS, Besancon, France; VEGF: PeproTech EC, London, UK; uPA, PAI-1: Biopool, Umea, Sweden; uPAR, PAI-2: American Diagnostica, Greenwich, Conn., USA). The levels of IL-8 and VEGF are expressed as pg/mg protein of the tissue extracts and those of uPA, uPAR, PAI-1, and PAI-2 are expressed as ng/mg protein of the tissue extracts. Protein concentrations were determined using the BCA Protein Assay Regent kit (BCA, Richmond, Calif., USA).
Statistical Analysis
Results of statistical analyses are expressed as the mean 8 SD. Statistical analysis was performed using a statistical software package (Statview 4.5; Abacus Concepts, Berkely, Calif., USA). The Spearman correlation coeffi cient (r) was used to evaluate the existence of correlations among IL-8, VEGF, and PA system factors. Student's t test was used to compare concentrations of IL-8, VEGF, and PA system factors in between normal and tumor tissues. The Mann-Whitney U test was used to evaluate the clinical relevance of different clinicopathological variables, together with IL-8, VEGF, and PA system factors. Survival was calculated from the date of surgery to the date of death or the last follow-up. The survival rate was estimated by the Kaplan-Meier method and analyzed by the log-rank test. To defi ne independent risk factors for prognosis, multivariate analysis was performed with Cox proportional hazards model. Differences were considered signifi cant when p ! 0.05.
Results
IL-8, VEGF, and PA System Factors in Normal and Tumor Tissues
The levels of IL-8, VEGF, uPAR, uPA, PAI-1, and PAI-2 in tumor tissues were all signifi cantly higher compared with the levels in normal tissues (all p ! 0.0001; table 1 ). 
Relationship between IL-8 and Clinicopathological Variables
The level of IL-8 was signifi cantly higher in large tumors ( 6 50 mm in diameter) than in small tumors ( ! 50 mm), and was also signifi cantly higher in subserosal-invaded and serosal-exposed tumors compared with mucosal and submucosal tumors. The IL-8 level was significantly higher in Dukes stage B-D tumors than in Dukes stage A tumors. In addition, the IL-8 level was higher in the tumors of patients with liver metastasis than in those without it ( table 2 ) .
Relationship of IL-8 with VEGF and PA System Factors
The IL-8 level was signifi cantly correlated with the VEGF level (r = 0.35, p ! 0.01), and was also signifi cantly correlated with the levels of uPAR, uPA, and PAI-1 ( table 3 ) .
Relationship of VEGF or PA System Factors with Clinicopathological Variables
The levels of VEGF, uPAR and PAI-1 were significantly higher in large ( 6 50 mm in diameter) than in small tumors ( ! 50 mm). The levels of uPAR and PAI-1 were also signifi cantly higher in subserosal-invaded and serosal-exposed tumors compared with mucosal and submucosal tumors. The PAI-1 level was signifi cantly lower in differentiated carcinoma. The VEGF level was higher in tumors with vascular involvement than in those without. The levels of uPAR and PAI-1 were signifi cantly higher in Dukes stage B-D tumors than in Dukes stage A tumors. In addition, the uPAR level was higher in the tumors of patients with liver metastasis than in those without it ( table 2 ). The VEGF level was signifi cantly correlated with the levels of uPAR and PAI-1 ( table 3 ) , and the levels of uPAR, uPA, and PAI-1 in tumor tissues were signifi cantly correlated with each other ( table 4 ). 
Survival
Univariate analysis revealed that high levels of IL-8, VEGF, and uPAR were signifi cantly associated with a shorter overall survival time ( table 5 ; fi g. 1 ). Multivariate analysis only identifi ed liver metastasis as an independent prognostic factor ( table 6 ).
Discussion
IL-8 was originally identifi ed as a leukocyte chemoattractant and a member of the CXC chemokine family. Although the precise mechanisms regulating IL-8 expression in tumor cells remain unknown, several studies have shown that IL-8 have some potential functions in CRC, including a role in angiogenesis, tumor growth, and metastasis [17, [30] [31] [32] . Brew et al. [3] demonstrated that exogenous IL-8 could stimulate the proliferation of colon carcinoma cell lines, while a neutralizing antibody for constitutively produced IL-8, or blockade of the actions of IL-8 by a specifi c antagonist peptide, both inhibited cell proliferation. Li et al. [33] showed a correlation between constitutive expression of IL-8 and its receptors in colon carcinoma cells with different metastatic potential. We demonstrated that the IL-8 level in tumor tissues was signifi cantly higher compared with that in normal tissues, and was signifi cantly correlated with tumor size, depth of infi ltration, Dukes stage, and liver metastasis. These results suggested that IL-8 contributed to the tumor growth, invasion, and metastasis in CRC.
Interestingly, the IL-8 level was signifi cantly correlated with the levels of uPAR, uPA, and PAI-1, as well as with the VEGF level. IL-8 stimulates uPA expression in human skin and human epidermal cells [8] . PAI-1 supports IL-8-mediated transendothelial migration of neutrophils [34] . This is the fi rst study to show quantitatively that IL-8 was correlated with PA system factors, uPA, uPAR, and PAI-1 in CRC. A positive correlation between VEGF overexpression and both uPAR expression and liver metastasis was demonstrated in our previous study [29] . In the present study, the VEGF level was quantitatively correlated with the levels of uPAR and PAI-1. VEGF has been shown to cause up-regulation of uPA, uPAR, and PAI-1 expression by endothelial cells [10, 35] . VEGF promotes the proliferation of endothelial cells and tube formation after degradation of the extracellular matrix by the PA system and/or MMP [10, 36] . Expression of VEGF and PA system factors have shown a positive correlation between VEGF and both uPA and uPAR expression using qualitative or quantitative methods [37, 38] .
Masuya et al. [39] reported that the levels of VEGF and IL-8 in tumor were associated with angiogenesis in non-small-cell lung carcinoma, but immunohistochemically they observed no correlation between VEGF and IL-8 expression. Kido et al. [17] reported that there was also no correlation between quantitative IL-8 and VEGF levels in gastric cancer; however, we observed a positive correlation between IL-8 and VEGF levels in the present study of CRC. These results indicate that both IL-8 and VEGF contribute to the progression of CRC, and it is possible that the activation of PAS by both angiogenic factors may promote malignant potential.
The levels of uPAR and PAI-1 were signifi cantly correlated with tumor size, depth of infi ltration, and Dukes stage, and the uPAR level was higher in tumors associated with liver metastasis than in those without it. Since uPA activity is expressed after binding to the uPAR on the cell surface, the uPAR level might be more important than that of uPA itself in the progression of CRC. The PAI-1 has also been shown to promote tumor growth and invasion by modifying cell adhesion independently of its uPA inhibitory activity [27, 28] . Modifi cations of cell ad- Table 6 . Cox proportional hazards model of overall survival hesion to the matrix by uPAR and PAI-1 appear to be intimately involved in tumor growth, invasion, and metastasis.
In conclusion, both IL-8 and VEGF are signifi cantly correlated with PA system factors, especially uPAR and PAI-1 in CRC, and IL-8 and uPAR are associated with liver metastasis. Both IL-8 and VEGF are responsible to the progression of CRC, and the activation of PAS by both factors play an important role in increase of malignant potential.
